Adiponectin test
Adiponectin is a hormone-like protein produced by the body's adipose tissue and plays an important role in the regulation of insulin sensitivity, energy metabolism, and inflammation. The biomarker is used in metabolic medicine and research to assess adipose tissue function, metabolic health, and the body's insulin sensitivity.
Low adiponectin levels are commonly seen in insulin resistance, abdominal obesity, metabolic syndrome, and type 2 diabetes. An adiponectin blood test may therefore provide complementary information regarding the body's metabolic balance in addition to traditional analyses such as glucose, HbA1c, and lipid levels.
The analysis is performed together with S-Leptin, another important adipose tissue-derived biomarker associated with energy metabolism, appetite regulation, and metabolic health. The combination of adiponectin and leptin may provide a broader assessment of adipose tissue function and metabolic regulation.
Adiponectin and leptin results are reported separately in your laboratory report.
Why is adiponectin analyzed?
Adiponectin analysis may be relevant for individuals seeking a deeper understanding of their metabolic health and insulin sensitivity. The biomarker is primarily used in specialized metabolic evaluation and research related to insulin resistance, obesity, and cardiometabolic disease.
An adiponectin blood test may be of interest in cases of:
- suspected insulin resistance
- abdominal obesity or obesity
- metabolic syndrome
- elevated blood glucose or type 2 diabetes
- fatty liver disease (NAFLD)
- elevated blood lipids
- evaluation of metabolic health and lifestyle interventions
- assessment of metabolic risk profile.
Adiponectin is not routinely analyzed in standard clinical care but has gained increasing attention as a biomarker of early metabolic dysfunction and impaired adipose tissue function.
Adiponectin and insulin resistance
Adiponectin is closely linked to the body's insulin sensitivity and plays an important role in the regulation of glucose and lipid metabolism. Low adiponectin levels are frequently observed in insulin resistance, a condition in which the body's cells respond less effectively to insulin signaling. As insulin sensitivity declines, the body must produce increasing amounts of insulin to maintain stable blood glucose levels, which over time may place additional strain on the pancreas and contribute to the development of type 2 diabetes and metabolic syndrome.
Low adiponectin levels are particularly common in individuals with increased visceral fat and abdominal obesity, where adipose tissue is often characterized by low-grade inflammation and metabolic dysfunction. Because adiponectin is associated with both insulin resistance and metabolic balance, the biomarker is sometimes used as a complementary analysis alongside glucose, HbA1c, insulin, and lipid profile testing when assessing metabolic health and the risk of metabolic disease.
Low and high adiponectin
Low adiponectin levels are common in metabolic dysfunction and are frequently associated with insulin resistance, type 2 diabetes, obesity, fatty liver disease, and increased cardiovascular risk.
Higher adiponectin levels are generally considered beneficial and are commonly associated with good insulin sensitivity and improved metabolic balance.
However, very high adiponectin levels may in some cases occur in advanced chronic disease, such as heart failure or catabolic conditions. Adiponectin results should therefore always be interpreted in relation to other laboratory findings, body composition, and the overall clinical context.
Adiponectin and leptin
Adiponectin analysis is performed together with S-Leptin because both biomarkers are closely linked to adipose tissue function and metabolic regulation. The combination of these biomarkers may provide a broader understanding of the body's energy balance, adipose tissue function, and insulin sensitivity.
Adiponectin and leptin results are reported separately in your laboratory report.
Adiponectin sampling and testing
Adiponectin is analyzed through a blood test. Fasting prior to sampling may be beneficial in metabolic evaluation but is generally not an absolute requirement. Levels are influenced by factors including body composition, insulin resistance, inflammation, physical activity, and the amount of visceral fat.
Adiponectin exhibits some diurnal variation, although these fluctuations are generally considered small and usually have limited clinical significance in routine testing.
